Mario Tiribelli, Associate Professor in Hematology at University of Udine, posted on LinkedIn:
“Excited to share our latest review on the role of monoclonal antibodies in the treatment of acute myeloid leukemia — an area of growing therapeutic promise.
This paper explores current advancements, clinical challenges, and future directions for antibody-based therapies in AML care. Thanks to prof. Daniela Damiani for leading this effort.”
Title: Monoclonal Antibodies Against Myeloid Leukemia Cells: Current Knowledge and Future Directions
Authors: Daniela Damiani and Mario Tiribelli
Read The Full Article at MDPI.
Read more posts featuring AML.